PharmaLeaders.com

News. Resources. Community.

  • Features
  • Channels
    • Biotech Channel
    • Clinical Channel
    • CME Channel
    • Compliance Channel
    • Device Channel
    • HIMSS Channel
    • Marketing Channel
    • Pharma Channel
    • R&D Channel
    • Telehealth Channel
    • Training Channel
  • Events
  • On Demand
  • White Papers
  • Vendors
    • Biotech Vendors
    • Clinical Vendors
    • CME Vendors
    • Compliance Vendors
    • Device Vendors
    • Marketing Vendors
    • Pharma Vendors
    • R&D Vendors
    • Training Vendors
  • Contributors

Featured Article

The Importance of Pharma Marketers Engaging with the Nation’s Leading Prescribers

11/21/2022 By Andrea

Contributed to PharmaLeaders by: Richard Zwickel, Chairman and CEO POCN Group Each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 cases are diagnosed in men. Nearly 42,500 people die from the disease annually. Nurse practitioners (NPs) and physician associates (PAs) take an active role in breast […]

Switching to omnichannel in pharma: What are the challenges?

08/17/2022 By Andrea

Article authored and contributed to PharmaLeaders by: Pavel Klymenko, Head of Omnichannel Hub at Viseven I’ve been in digital marketing for more than 15 years. From the beginning of my career, I witnessed the evolution of online communication in different markets. With the increasing number of messages sent by many companies via multiple platforms, customers got […]

More from this Category

White Papers

Engaging Users of Healthcare Provider Communities

Ninety-nine percent of all U.S. More about the punters page physicians use the Internet to gather clinical information. Sixty percent of healthcare … FREE Download

Whitepaper about Data Compliance and Healthcare Marketing

Whitepaper: Execute a 5-Step Framework for Data Compliance in Healthcare Marketing in the 2020s

The 2020s will transform how consumers and businesses interact with each other as vast amounts of personal and contextually relevant data will be … FREE Download

Industry News

AFT and Salus Pharmaceuticals sign agreement for pain treatment Maxigesic IV

02/02/2023

Under the terms of the partnership deal between the companies, Hyloris will receive a share on any revenues related to product, such as royalties, license fees, milestone payments, The post AFT and Salus Pharmaceuticals sign agreement for pain treatment Maxigesic IV appeared first on Pharmaceutical … [Read More...]

GSK receives orphan drug designation for Benlysta to treat systemic sclerosis

02/02/2023

Initially, the FDA approved Benlysta for the treatment of active systemic lupus erythematosus (SLE). GSK noted that it is the first and only approved biologic for SLE as The post GSK receives orphan drug designation for Benlysta to treat systemic sclerosis appeared first on Pharmaceutical Business … [Read More...]

TScan Therapeutics receives FDA clearance for IND applications

02/01/2023

Serving as the primary IND for TScan’s solid tumour programme, T-Plex will enable customised combinations of T cell receptor (TCR)-engineered T cell therapies (TCR-T) to be given to The post TScan Therapeutics receives FDA clearance for IND applications appeared first on Pharmaceutical Business … [Read More...]

US FDA grants fast track designation to Artiva’s lead programme AB-101

02/01/2023

AB-101 is a non-genetically modified, cord blood-derived, allogeneic, cryopreserved, ADCC-enhancing NK cell therapy candidate for use along with monoclonal antibodies or innate-cell engagers in the out-patient environment. Artiva The post US FDA grants fast track designation to Artiva’s lead … [Read More...]

More from this Category

  • Facebook
  • LinkedIn
  • Twitter

Choose Your Channel

Receive event announcements and special reports directly in your inbox.
  • This field is for validation purposes and should be left unchanged.

Upcoming Events

  1. 6th CAR-TCR Summit Europe

    February 21 - February 23
  2. 7th Virtual Clinical Trials Summit

    May 16 - May 17

View All Events

  • About Us
  • Sponsorship
  • Join Our Team
  • Contact Us

Copyright © 2023 PharmaLeaders.com. All rights reserved.